Accelerate Diagnostics Inc
General ticker "AXDX" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $36.2M
Accelerate Diagnostics Inc does not follow the US Stock Market performance with the rate: -4.3%.
Estimated limits based on current volatility of 4.7%: low 1.09$, high 1.20$
Factors to consider:
- US accounted for 85.6% of revenue in the fiscal year ended 2022-12-31
- Current price 61.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.90$, 7.65$]
- 2024-12-30 to 2025-12-30 estimated range: [2.34$, 6.19$]
Financial Metrics affecting the AXDX estimates:
- Negative: Non-GAAP EPS, $ of -5.87 <= 0.10
- Negative: Operating profit margin, % of -81.75 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -41.99 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85
Short-term AXDX quotes
Long-term AXDX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $11.78MM | $12.75MM | $12.06MM |
| Operating Expenses | $83.34MM | $75.56MM | $66.09MM |
| Operating Income | $-71.56MM | $-62.80MM | $-54.03MM |
| Non-Operating Income | $-6.10MM | $0.23MM | $-6.74MM |
| Interest Expense | $15.54MM | $3.77MM | $7.74MM |
| R&D Expense | $21.94MM | $26.91MM | $25.35MM |
| Income(Loss) | $-77.66MM | $-62.57MM | $-60.77MM |
| Taxes | $0.04MM | $-0.08MM | $0.85MM |
| Profit(Loss) | $-77.70MM | $-62.49MM | $-61.62MM |
| Stockholders Equity | $-35.07MM | $-22.26MM | $-19.89MM |
| Inventory | $5.07MM | $5.19MM | $3.31MM |
| Assets | $83.05MM | $65.02MM | $31.37MM |
| Operating Cash Flow | $-47.32MM | $-48.73MM | $-40.20MM |
| Capital expenditure | $0.60MM | $0.55MM | $1.03MM |
| Investing Cash Flow | $8.30MM | $12.42MM | $8.66MM |
| Financing Cash Flow | $43.23MM | $31.63MM | $9.02MM |
| Earnings Per Share* | $-12.59 | $-7.61 | $-4.94 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.